Molecular biology of the cell cycle: Potential for therapeutic applications in radiation oncology

The cell cycle was first described by radiation biologists more than 40 years ago. Since then, radiation oncologists have used information regarding the cell cycle, in particular cell cycle kinetics, to design various treatment protocols; these have resulted in only modest improvements in patient ou...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in radiation oncology 1996-10, Vol.6 (4), p.284-294
Main Authors: Rudoltz, Marc S., Kao, Gary, Blank, Kenneth R., Muschel, Ruth J., Gillies McKenna, W.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c278t-5db161e5937003d27a7040d21aefb0b999f9e6cd5702344b561d407a708146043
cites cdi_FETCH-LOGICAL-c278t-5db161e5937003d27a7040d21aefb0b999f9e6cd5702344b561d407a708146043
container_end_page 294
container_issue 4
container_start_page 284
container_title Seminars in radiation oncology
container_volume 6
creator Rudoltz, Marc S.
Kao, Gary
Blank, Kenneth R.
Muschel, Ruth J.
Gillies McKenna, W.
description The cell cycle was first described by radiation biologists more than 40 years ago. Since then, radiation oncologists have used information regarding the cell cycle, in particular cell cycle kinetics, to design various treatment protocols; these have resulted in only modest improvements in patient outcome. Over the past 10 to 15 years there has been an explosion of scientific knowledge regarding the cell cycle, in particular the molecular regulation of the cell cycle checkpoints. In this review we will discuss the genetic events involved in regulating the G1 and G2 checkpoints and how this information may lead to future therapeutic breakthroughs. In addition we will discuss the potential clinical impact of the recent cloning of the gene for ataxia telangiectasia.
doi_str_mv 10.1016/S1053-4296(96)80024-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1859321114</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1053429696800245</els_id><sourcerecordid>1859321114</sourcerecordid><originalsourceid>FETCH-LOGICAL-c278t-5db161e5937003d27a7040d21aefb0b999f9e6cd5702344b561d407a708146043</originalsourceid><addsrcrecordid>eNqFkM1q3TAQRkVpaX7aR2jQMlm41ciSbGVTQmjTQEIKTdZClsatgq7lSnbgvn3texPoLiCQBp35hjmEfAL2GRioL7-AyboSXKtTrc5axrio5BtyCLLmlRYK3i7vF-SAHJXyuDDQcP2eHABroIFWHRJ7myK6OdpMu5Bi-r2lqafTH6QOY6Ru6yKe059pwmEKNtI-5fU32xHnKThqxzEGZ6eQhkLDQLP1YVfRNLhd3gfyrrex4Mfn-5g8fP92f_mjurm7ur68uKkcb9qpkr4DBSh13TBWe97YhgnmOVjsO9ZprXuNynnZMF4L0UkFXrCVakEoJupjcrrPHXP6O2OZzCaUdQk7YJqLgXbJ5gCwonKPupxKydibMYeNzVsDzKx2zc6uWdWZ5ezsGrn0nTyPmLsN-v-69joX4OsewGXRp4DZFBdwcOhDRjcZn8IrI_4BqgmJaw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1859321114</pqid></control><display><type>article</type><title>Molecular biology of the cell cycle: Potential for therapeutic applications in radiation oncology</title><source>ScienceDirect Journals</source><creator>Rudoltz, Marc S. ; Kao, Gary ; Blank, Kenneth R. ; Muschel, Ruth J. ; Gillies McKenna, W.</creator><creatorcontrib>Rudoltz, Marc S. ; Kao, Gary ; Blank, Kenneth R. ; Muschel, Ruth J. ; Gillies McKenna, W.</creatorcontrib><description>The cell cycle was first described by radiation biologists more than 40 years ago. Since then, radiation oncologists have used information regarding the cell cycle, in particular cell cycle kinetics, to design various treatment protocols; these have resulted in only modest improvements in patient outcome. Over the past 10 to 15 years there has been an explosion of scientific knowledge regarding the cell cycle, in particular the molecular regulation of the cell cycle checkpoints. In this review we will discuss the genetic events involved in regulating the G1 and G2 checkpoints and how this information may lead to future therapeutic breakthroughs. In addition we will discuss the potential clinical impact of the recent cloning of the gene for ataxia telangiectasia.</description><identifier>ISSN: 1053-4296</identifier><identifier>EISSN: 1532-9461</identifier><identifier>DOI: 10.1016/S1053-4296(96)80024-5</identifier><identifier>PMID: 10717186</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><ispartof>Seminars in radiation oncology, 1996-10, Vol.6 (4), p.284-294</ispartof><rights>1996 W.B. Saunders Company. All rights reserved</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c278t-5db161e5937003d27a7040d21aefb0b999f9e6cd5702344b561d407a708146043</citedby><cites>FETCH-LOGICAL-c278t-5db161e5937003d27a7040d21aefb0b999f9e6cd5702344b561d407a708146043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10717186$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rudoltz, Marc S.</creatorcontrib><creatorcontrib>Kao, Gary</creatorcontrib><creatorcontrib>Blank, Kenneth R.</creatorcontrib><creatorcontrib>Muschel, Ruth J.</creatorcontrib><creatorcontrib>Gillies McKenna, W.</creatorcontrib><title>Molecular biology of the cell cycle: Potential for therapeutic applications in radiation oncology</title><title>Seminars in radiation oncology</title><addtitle>Semin Radiat Oncol</addtitle><description>The cell cycle was first described by radiation biologists more than 40 years ago. Since then, radiation oncologists have used information regarding the cell cycle, in particular cell cycle kinetics, to design various treatment protocols; these have resulted in only modest improvements in patient outcome. Over the past 10 to 15 years there has been an explosion of scientific knowledge regarding the cell cycle, in particular the molecular regulation of the cell cycle checkpoints. In this review we will discuss the genetic events involved in regulating the G1 and G2 checkpoints and how this information may lead to future therapeutic breakthroughs. In addition we will discuss the potential clinical impact of the recent cloning of the gene for ataxia telangiectasia.</description><issn>1053-4296</issn><issn>1532-9461</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqFkM1q3TAQRkVpaX7aR2jQMlm41ciSbGVTQmjTQEIKTdZClsatgq7lSnbgvn3texPoLiCQBp35hjmEfAL2GRioL7-AyboSXKtTrc5axrio5BtyCLLmlRYK3i7vF-SAHJXyuDDQcP2eHABroIFWHRJ7myK6OdpMu5Bi-r2lqafTH6QOY6Ru6yKe059pwmEKNtI-5fU32xHnKThqxzEGZ6eQhkLDQLP1YVfRNLhd3gfyrrex4Mfn-5g8fP92f_mjurm7ur68uKkcb9qpkr4DBSh13TBWe97YhgnmOVjsO9ZprXuNynnZMF4L0UkFXrCVakEoJupjcrrPHXP6O2OZzCaUdQk7YJqLgXbJ5gCwonKPupxKydibMYeNzVsDzKx2zc6uWdWZ5ezsGrn0nTyPmLsN-v-69joX4OsewGXRp4DZFBdwcOhDRjcZn8IrI_4BqgmJaw</recordid><startdate>199610</startdate><enddate>199610</enddate><creator>Rudoltz, Marc S.</creator><creator>Kao, Gary</creator><creator>Blank, Kenneth R.</creator><creator>Muschel, Ruth J.</creator><creator>Gillies McKenna, W.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199610</creationdate><title>Molecular biology of the cell cycle: Potential for therapeutic applications in radiation oncology</title><author>Rudoltz, Marc S. ; Kao, Gary ; Blank, Kenneth R. ; Muschel, Ruth J. ; Gillies McKenna, W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c278t-5db161e5937003d27a7040d21aefb0b999f9e6cd5702344b561d407a708146043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rudoltz, Marc S.</creatorcontrib><creatorcontrib>Kao, Gary</creatorcontrib><creatorcontrib>Blank, Kenneth R.</creatorcontrib><creatorcontrib>Muschel, Ruth J.</creatorcontrib><creatorcontrib>Gillies McKenna, W.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in radiation oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rudoltz, Marc S.</au><au>Kao, Gary</au><au>Blank, Kenneth R.</au><au>Muschel, Ruth J.</au><au>Gillies McKenna, W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular biology of the cell cycle: Potential for therapeutic applications in radiation oncology</atitle><jtitle>Seminars in radiation oncology</jtitle><addtitle>Semin Radiat Oncol</addtitle><date>1996-10</date><risdate>1996</risdate><volume>6</volume><issue>4</issue><spage>284</spage><epage>294</epage><pages>284-294</pages><issn>1053-4296</issn><eissn>1532-9461</eissn><abstract>The cell cycle was first described by radiation biologists more than 40 years ago. Since then, radiation oncologists have used information regarding the cell cycle, in particular cell cycle kinetics, to design various treatment protocols; these have resulted in only modest improvements in patient outcome. Over the past 10 to 15 years there has been an explosion of scientific knowledge regarding the cell cycle, in particular the molecular regulation of the cell cycle checkpoints. In this review we will discuss the genetic events involved in regulating the G1 and G2 checkpoints and how this information may lead to future therapeutic breakthroughs. In addition we will discuss the potential clinical impact of the recent cloning of the gene for ataxia telangiectasia.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>10717186</pmid><doi>10.1016/S1053-4296(96)80024-5</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1053-4296
ispartof Seminars in radiation oncology, 1996-10, Vol.6 (4), p.284-294
issn 1053-4296
1532-9461
language eng
recordid cdi_proquest_miscellaneous_1859321114
source ScienceDirect Journals
title Molecular biology of the cell cycle: Potential for therapeutic applications in radiation oncology
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T22%3A35%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20biology%20of%20the%20cell%20cycle:%20Potential%20for%20therapeutic%20applications%20in%20radiation%20oncology&rft.jtitle=Seminars%20in%20radiation%20oncology&rft.au=Rudoltz,%20Marc%20S.&rft.date=1996-10&rft.volume=6&rft.issue=4&rft.spage=284&rft.epage=294&rft.pages=284-294&rft.issn=1053-4296&rft.eissn=1532-9461&rft_id=info:doi/10.1016/S1053-4296(96)80024-5&rft_dat=%3Cproquest_cross%3E1859321114%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c278t-5db161e5937003d27a7040d21aefb0b999f9e6cd5702344b561d407a708146043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1859321114&rft_id=info:pmid/10717186&rfr_iscdi=true